-
Startseite
-
a-t-Inhaltsverzeichnis
-
a-t-Volltextsuche
für Nichtabonnenten
-
Bereich für Abonnenten
   blitz-a-t
   e a-t
   a-t-Volltextregister
   NETZWERK-UAW
   Leserpost
-
atd Arzneimitteldatenbank
-
Glossar
-
a-t englisch  
   Current issue
   Archive
-
Bestellungen
   arznei-telegramm
   Bücher, CD,
   Sammelmappen
   atd
   Arzneimitteldatenbank
   Mitteilung
   an den Vertrieb
-
Wir über uns
-
Impressum
-
Datenschutz
-
  
 
  Volume 35, 2 April 2004 4/2004
 
  SPOT ON
 

Adjuvant treatment of breast cancer: early switch to exemestane (AROMASIN)?

 
  NEW ON THE MARKET
 

Fulvestrant (FASLODEX) for advanced breast cancer

 
  REVIEW
 

Drug-eluting stents

 
  THERAPIES FROM A CRITICAL VIEW POINT
 

Infliximab (REMICADE) for fistulising CROHN's disease
Acute coronary syndrome: Atorvastatin better than Pravastatin?

 
  QUALITY ASSESSMENT
 

Quality of enalapril (e.g. PRES) products

 
  BEWARE! MISSINFORMATION
 

Pimecrolimus (e.g. ELIDEL) for atopic dermatitis
Prophylaxis of migraine headaches with butterbur root (PETADOLEX):
standard of treatment according to a new guideline?

 
  IN BRIEF
 

Prematurity and chronic lung disease: late outcomes of dexamethasone therapy
Patent expiration for carvedilol (DILATREND, QUERTO)
Antibacterial products in households unneccessary

 
  CURRENT ADR NETWORK REPORT

Long-acting injectable risperidone (RISPERDAL CONSTA):
anxiety and aggressive outbursts

 
© arznei-telegramm 4/2004